Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.
Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.
复制标题
DOI:
10.4049/immunohorizons.2000068
复制
发表时间:
2020-08-04
期刊:
影响因子:
--
通讯作者:
Koelle DM
中科院分区:
文献类型:
--
作者:
Campbell VL;Nguyen L;Snoey E;McClurkan CL;Laing KJ;Dong L;Sette A;Lindestam Arlehamn CS;Altmann DM;Boyton RJ;Roby JA;Gale M Jr;Stone M;Busch MP;Norris PJ;Koelle DM
Zika virus (ZIKV) is a mosquito-borne pathogen that caused an epidemic in 2015–2016. ZIKV-specific T cell responses are functional in animal infection models, and helper CD4 T cells promote avid antibodies in the vaccine context. The small volumes of blood available from field research limit the determination of T cell epitopes for complex microbes such as ZIKV. The goal of this project was efficient determination of human ZIKV CD4 T cell epitopes at whole proteome scale, including validation of reactivity to whole pathogen, using small blood samples from convalescent time points when T cell response magnitude may have waned. Polyclonal enrichment of candidate ZIKV-specific CD4 T cells used cell-associated virus, documenting that T cells in downstream peptide analyses also recognize whole virus after antigen processing. Sequential query of bulk ZIKV-reactive CD4 T cells with pooled/single ZIKV peptides and molecularly defined antigen presenting cells (APC) allowed precision epitope and HLA restriction assignments across the ZIKV proteome and enabled discovery of numerous novel ZIKV CD4 T cell epitopes. The research workflow is useful for the study of emerging infectious diseases with very limited blood sample availability.